Skip to content
Skip to institutional links

Alzheimer’s strategy news

2013

Summary of Alzheimer’s disease research articles using ADNI data published
American researchers have recently published a review of about 200 articles published using Alzheimer’s Disease Neuroimaging Initiative (ADNI) data. Since 2010, CIHR has been helping connect Canadian researchers to the unprecedented clinical and imaging data available through ADNI. This review provides a good overview of the major advancements recently made in Alzheimer’s disease research with the help of ADNI.
BigBrain: Canadian scientists create the most detailed 3D map of the human brain
Blocking overactive receptor in Alzheimer's recovers memory loss and more
Exercise can reduce onset of Alzheimer's
CIHR funding advances research of potential new treatment for Alzheimer's
Alzheimer’s Strategy Leveraging International Datasets
The Alzheimer’s Strategy is helping to better connect Canadian researchers to unprecedented clinical and imaging data about Alzheimer’s and related dementia. Using publicly available data from the International Alzheimer’s Disease Neuroimaging Initiative (ADNI), Canadian researchers will advance our knowledge of early detection and hopefully find cues to better understand the disease.
A new technology to detect and diagnose Alzheimer's
JPND launches two calls for research proposals
Countries around the globe are faced with an increasing number of people with Alzheimer's disease or related dementias. To address the global challenge, the European Union Joint Programme — Neurodegenerative Diseases (JPND) is launching two calls for proposals in the field of neurodegenerative disease research. As part of CIHR's International Collaborative Research Strategy for Alzheimer's Disease, Canada joined JPND in 2012. With this partnership and others fostered under CIHR's International Alzheimer's Strategy, Canadian researchers benefit from the synergies which will provide Canadians with the best preventative, diagnostic and treatment approaches.
CIHR participates in key international meeting about neurodegeneration research
In November 2012, CIHR Institute of Aging Scientific Director, Dr. Yves Joanette, participated in the European Union Joint Programme – Neurodegenerative Disease Research (JPND) meeting in Washington. He presented Canada’s dementia research plan and experience participating in the JPND as the program’s first non-European Union member. CIHR’s International Collaborative Research Strategy for Alzheimer's Disease, which aims to give Canadians rapid access to the latest approaches to preventing, diagnosing and treating Alzheimer's disease and related dementias, has facilitated the participation of Canadian researchers in key international partnerships.
A major step in the fight against Alzheimer's disease
CIHR Café Scientifique on January 28: Myths vs. Realities: Understanding dementia after diagnosis
January 2013 - Alzheimer Awareness Month – Let's talk about dementia
January marks Alzheimer Awareness Month. In Canada, 747,000 people currently live with dementia and one of the major challenges they and their families face when they receive the diagnosis is the stigma associated with it. In fact, according to a recent poll by Alzheimer's Disease International, 40 per cent of people with dementia reported they had been avoided or treated differently after diagnosis. That's why, this January during Alzheimer Awareness Month, the Alzheimer Society Canada is launching a nation-wide campaign called "See me, not my disease. Let's talk about dementia". CIHR is proud to team up with the Alzheimer Society to further inform Canadians about the myths and stigma surrounding the disease.

2012

2011